Results 371 to 380 of about 1,067,293 (391)
Some of the next articles are maybe not open access.
Postgraduate Medicine, 1980
In this article, qualitative and quantitative aspects of the "benign" myeloid leukocytoses are discussed. Although leukemia has been excluded from the discussion, it is clear that the so-called benign myeloid leukocytoses may on occasion reflect malignant disease--notably of the solid tumor variety. Absolute counts, left shifts, and leukemoid reactions
openaire +3 more sources
In this article, qualitative and quantitative aspects of the "benign" myeloid leukocytoses are discussed. Although leukemia has been excluded from the discussion, it is clear that the so-called benign myeloid leukocytoses may on occasion reflect malignant disease--notably of the solid tumor variety. Absolute counts, left shifts, and leukemoid reactions
openaire +3 more sources
Hematology/Oncology Clinics of North America, 2009
The evolution of acute myeloid leukemia (AML) classification reflects greater understanding of the AML pathogenesis. The 2008 World Health Organization classification incorporated cytogenetic and molecular genetic findings and introduced important prognostic correlations.
Amy, Heerema-McKenney, Daniel A, Arber
openaire +2 more sources
The evolution of acute myeloid leukemia (AML) classification reflects greater understanding of the AML pathogenesis. The 2008 World Health Organization classification incorporated cytogenetic and molecular genetic findings and introduced important prognostic correlations.
Amy, Heerema-McKenney, Daniel A, Arber
openaire +2 more sources
Clinics in Laboratory Medicine, 2017
The classification of myeloid neoplasms has undergone major changes and currently relies heavily on genetic abnormalities. Cutaneous manifestations of myeloid neoplasms may be the presenting sign of underlying bone marrow disease. Dermal infiltration by neoplastic cells may occur in otherwise normal skin or in sites of cutaneous inflammation.
openaire +2 more sources
The classification of myeloid neoplasms has undergone major changes and currently relies heavily on genetic abnormalities. Cutaneous manifestations of myeloid neoplasms may be the presenting sign of underlying bone marrow disease. Dermal infiltration by neoplastic cells may occur in otherwise normal skin or in sites of cutaneous inflammation.
openaire +2 more sources
Current Opinion in Hematology, 1997
Progress has been made in understanding BCR-ABL-positive leukemias. A new transcript (p230BCR-ABL) has been characterized that is associated with Ph-positive chronic neutrophilic leukemia. The ATM protein appears to be a regulator of ABL activity in response to irradiation damage.
John M. Goldman, Michael W. Deininger
openaire +4 more sources
Progress has been made in understanding BCR-ABL-positive leukemias. A new transcript (p230BCR-ABL) has been characterized that is associated with Ph-positive chronic neutrophilic leukemia. The ATM protein appears to be a regulator of ABL activity in response to irradiation damage.
John M. Goldman, Michael W. Deininger
openaire +4 more sources
Myeloid sarcoma of the stomach
Gastrointestinal Endoscopy, 2008醫學系內科 ; 醫學系 ; 醫學院 ...
WANG, WEN-LUN +2 more
openaire +4 more sources
Immunotherapy of myeloid leukaemia
Cancer Immunology, Immunotherapy, 2006The treatment of myeloid leukaemia has progressed in recent years with the advent of donor leukocyte infusions (DLI), haemopoietic stem cell transplants (HSCTs) and targeted therapies. However, relapse has a high associated morbidity rate and a method for removing diseased cells in first remission, when a minimal residual disease state is achieved and ...
Guinn, Barbara-Ann +3 more
openaire +4 more sources
Nature Reviews Disease Primers, 2016
Acute myeloid leukaemia (AML) is a disorder characterized by a clonal proliferation derived from primitive haematopoietic stem cells or progenitor cells. Abnormal differentiation of myeloid cells results in a high level of immature malignant cells and fewer differentiated red blood cells, platelets and white blood cells. The disease occurs at all ages,
David A. Scheinberg +12 more
openaire +3 more sources
Acute myeloid leukaemia (AML) is a disorder characterized by a clonal proliferation derived from primitive haematopoietic stem cells or progenitor cells. Abnormal differentiation of myeloid cells results in a high level of immature malignant cells and fewer differentiated red blood cells, platelets and white blood cells. The disease occurs at all ages,
David A. Scheinberg +12 more
openaire +3 more sources
The Lancet, 2007
Chronic myeloid leukaemia (CML) was the first neoplastic disease for which knowledge of the genotype led to a rationally designed therapy. As a result of its well known pathophysiology, straightforward diagnosis, well established prognostic factors, and treatment for the cause of disease, CML has been studied to an extent that far exceeds that expected
Hehlmann R +3 more
openaire +4 more sources
Chronic myeloid leukaemia (CML) was the first neoplastic disease for which knowledge of the genotype led to a rationally designed therapy. As a result of its well known pathophysiology, straightforward diagnosis, well established prognostic factors, and treatment for the cause of disease, CML has been studied to an extent that far exceeds that expected
Hehlmann R +3 more
openaire +4 more sources
Current Opinion in Oncology, 1992
Chronic myeloid leukemia is a clonal myeloproliferative disorder of a pluripotent stem cell with a specific cytogenetic abnormality, the Philadelphia chromosome, involving myeloid, erythroid, megakaryocytic, B lymphoid, and sometimes T lymphoid cells but not marrow fibroblasts.
openaire +5 more sources
Chronic myeloid leukemia is a clonal myeloproliferative disorder of a pluripotent stem cell with a specific cytogenetic abnormality, the Philadelphia chromosome, involving myeloid, erythroid, megakaryocytic, B lymphoid, and sometimes T lymphoid cells but not marrow fibroblasts.
openaire +5 more sources